Member Info for CHELSEA7

No cumbs, not yet, if available he normally redponds within 24 hours. Makes me think along with the speed we are falling we could expect an RNS this week.

Bermuda, yes I have seen that, Ruck made a point of saying they nodded, mor than prepared to accept that, but still something doesn"t sound right and if that is corect yes news this week will be the only way to clarify the situation, the market at least has made up their minds.

Wouldn"t be surprised at all to see one tomorrow or Wednesday

Yeah really good news. Makes you wonder how they enrolled so many patients, untreated, suggesting late diagnosis and in Stage 4 , which doesnt give much time to enrol and treat. Are we really struggling to enrol and screen 6 patients???

Strange day today SP wise, they took us down quickly which normally means taking shares to fill a large order, possibly at 5.50 and the MMs at that point went to taking 210k+ shares. Those two trades sell trades at 5.025, 50k and 20k didn"t make much sense as the bid was 5.16 at the time, no delayed buy came and the ask slowly went down to 5.39 despite full ask being paid for 65k. Just a 70k difference between buys/sells, but -7.08%, something seems missing from that picture.

I nearly bought 40k at the end, seems signs that quite a few will top up approaching 5p, have to sleep on that, just a lousy time of year for finding that for me, and we had 24 trades today, the most for quite some time, with the volume just falling short of 1m, or was it??

Puzzled over recruitment for this trial, people tend to look to the BOD for blame, but there is enough experience in senior positions now to question whether the BOD actually stated for sure they will inform us of recruitment at every juncture. Ruck said they nodded, hmmm?

Night guys, tomorrow could be quite an interesting day, and I am watching this 100k seller like a hawk. Catch yer tomoz ATB

Buys 435k

Sells 503k

-7.08%?

Wonder why??

MMs still will take 210k+ at 5.16

For 65k

And 2 sells 50k and 20k at 5.025??

Could well be a delayed sell to come, and that big buy I mentioned, lol

Buys 315k

Sells 433k

-7.08% ??

https://www.fiercepharma.com/special-report/biopharma-s-broken-promises?mkt_tok=eyJpIjoiTVRkaE1UZGtOekF6T1RjeSIsInQiOiI4b0VHSzJhd3VLMVVOQ2k1enFwU1Z6RGtieXpYQitNTHpEa05LaXRCZmF6WHFGdGZTVml1OG1MMFRXQUhocWhnMHo2NnRFQVdZUlhhZk1RNkJEd21raDVkRE9GM1B0blNaYXZiZzJPaEFwM2xRTUNLdzZCemFiaFpPS3kzVm0xNCJ9&mrkid=36433381

Hmmm.............."""Of course, drugmakers and executives routinely roll out their “forward-looking statements” warning shareholders that they don’t in fact know how the future will play out. Changing circumstances often require changing strategies. Still, it's worth noting some promises by industry leaders that end up playing out."""

Both buys.......................

37k at 5.39

4k at 5.395

Crumbs, re SCIB1 in China...........................

""The incidence of melanoma in China was relatively low, accounting for 1%–3% among that of all malignant tumors. However, the number of new cases in China each year is more than 20,000 [7], and currently has the highest incidence in all malignant tumors, with an annual growth rate of approximately 3% -5% [8].18 Nov 2016"""

However, with SCIB2 in mind (NSCLC).

Incidence of NSCLC in China
The age-adjusted incidence was 39.05 per 100 000 people overall, 41.43 per 100 000 people in males and 37.13 per 100 000 people in females, based on the World Standard Population (table 1).

Interesting article from China...........Opvido/Yervoy in NSCLC...............thinking of SCIB2

https://immuno-oncologynews.com/2019/10/08/opdivo-yervoy-combo-prolongs-survival-in-patients-with-advanced-nsclc-phase-3-study-shows/

""Bristol-Myers Squibb has announced that the main goal of Part 2 — to assess whether combining Opdivo and chemotherapy led to a significantly greater overall survival compared to chemotherapy alone — was not achieved.""

Again!!

Over 215k now at 5.16

Behaving as it did when i used to say big buy coming.

Big Buy Coming, lol!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Well we have mentioned China quite a lot in the last few years. That is one big investment by China in hospitals, and 4m people diagnosed each year with cancer. Would have thought SCIB1 could have been a cost effective treatment for those patients with Melanoma?

Lets get a listing in Hong Kong, lol!!!

Up to 100k at 5.15

Over 200k+ 5.11

Tick up Coming?

Buys 260k

Sells 433k

-7.08%

Not really, I just buy through H/Land pay £11.95 a trade, otherwise I would add as you do.

Crumbs, just thinking the same, didn"t want to add more, especially this time of year, lol, but yes seems from 10p another buying opportunity.

Hoping CH replies and mentions any possibility of re submitting IND soon, that would be very good news.

2 Buys...........................1 Sell

12:55:29 5.411 10,000 541.10 O
12:47:55 5.45 54,881 2,991 O
12:40:55 5.10 30,000 1,530

Just to let you know just sent this, and will advise on any reply, hope it covers manys concerns...............

Mon 28/10/2019 12:38
Morning Cliff,

Hoping you are well. Don"t like mithering you on negatives, we have shared a few good positive posts in the last few months for balance.

Back to a reccuring problem with the share price down another 7% today, currently 5/5.50, we have another 100k seller it would seem, but
the problem I highlighted to you the last time we spoke is more evident than ever. We have been falling as you know heavily the last few weeks,
presumably it is because of delays to enrolling patients for SCIB1 trial. I understand your problems in not RNSing any update, the SP would have
fallen sharply on that news, but it is the lack of any good news IMHO that PIs are needing. All adding up again to the BOD not supporting the share
again, I just hope Vulpes or any ii start to build a holding at this level.

Understand too, that you cant say too much, but I said I would relay our thoughts as and when.

Lets hope for a quick turn around, nothing is more demoralising for us and you to see us fall from a high of 10p to just 5p.

My very best regards to you all.

Paul